Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SagaMedica is an Icelandic biotechnology company specializing in the development and manufacture of natural health products derived from Icelandic medicinal herbs. Founded on the research of Dr. Sigmundur Gudbjarnason, the company focuses on the therapeutic potential of Angelica archangelica, harvested sustainably from the Icelandic wilderness. Its lead product, SagaPro, is a clinically studied extract used to improve bladder health and reduce the frequency of nighttime urination. The company also produces Voxis lozenges for respiratory relief and SagaVita for immune support. SagaMedica combines traditional herbal knowledge with modern scientific validation to provide high-quality, natural solutions for common health concerns.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SagaMedica.